Your browser doesn't support javascript.
loading
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
Tolaney, Sara M; Tayob, Nabihah; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Hu, Jiani; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Briccetti, Frederick; Schneider, Bryan; Garrett, Audrey Merrill; Marcom, Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta; Ruddy, Kathryn; Zheng, Yue; Rosenberg, Shoshana M; Gelber, Richard D; Trippa, Lorenzo; Barry, William; DeMeo, Michelle; Burstein, Harold; Partridge, Ann; Winer, Eric P; Krop, Ian.
Affiliation
  • Tolaney SM; Dana-Farber Cancer Institute, Boston, MA.
  • Tayob N; Harvard Medical School, Boston, MA.
  • Dang C; Dana-Farber Cancer Institute, Boston, MA.
  • Yardley DA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Isakoff SJ; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.
  • Valero V; Massachusetts General Hospital, Boston, MA.
  • Faggen M; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mulvey T; Dana-Farber Cancer Institute, Boston, MA.
  • Bose R; Massachusetts General Hospital, Boston, MA.
  • Hu J; Washington University, St Louis, MO.
  • Weckstein D; Dana-Farber Cancer Institute, Boston, MA.
  • Wolff AC; Dana-Farber Cancer Institute, Boston, MA.
  • Reeder-Hayes K; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.
  • Rugo HS; UNC Chapel Hill, Chapel Hill, NC.
  • Ramaswamy B; UCSF, San Francisco, CA.
  • Zuckerman D; OSU Comprehensive Cancer Center, Columbus, OH.
  • Hart L; St Luke's Mountain States Tumor Institute, Boise, ID.
  • Gadi VK; Wake Forest Baptist Health, Winston-Salem, NC.
  • Constantine M; University of Washington, Seattle, WA. Currently at University of Illinois at Chicago, Chicago, IL.
  • Cheng K; Dana-Farber Cancer Institute, Boston, MA.
  • Briccetti F; North Shore-LIJ Cancer Institute, Lake Success, NY.
  • Schneider B; Dana-Farber Cancer Institute, Boston, MA.
  • Garrett AM; IU School of Medicine, Indianapolis, IN.
  • Marcom K; Northern Light Cancer Care, Brewer, ME.
  • Albain K; Duke University, Durham, NC.
  • DeFusco P; Loyola University Medical Center, Maywood, IL.
  • Tung N; Hartford Healthcare Cancer Institute, Hartford, CT.
  • Ardman B; Harvard Medical School, Boston, MA.
  • Nanda R; Beth Israel Deaconess Medical Center, Boston, MA.
  • Jankowitz RC; Lowell General Hospital, Lowell, MA.
  • Rimawi M; The University of Chicago, Chicago, IL.
  • Abramson V; Abramsom Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Pohlmann PR; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.
  • Van Poznak C; Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Forero-Torres A; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Liu M; Rogel Cancer Center, University of Michigan, Ann Arbor, MI.
  • Ruddy K; Kirklin UAB Hematology Oncology, Birmingham, AL.
  • Zheng Y; Mayo Clinic, Rochester, MN.
  • Rosenberg SM; Mayo Clinic, Rochester, MN.
  • Gelber RD; Dana-Farber Cancer Institute, Boston, MA.
  • Trippa L; Dana-Farber Cancer Institute, Boston, MA.
  • Barry W; Harvard Medical School, Boston, MA.
  • DeMeo M; Dana-Farber Cancer Institute, Boston, MA.
  • Burstein H; Harvard Medical School, Boston, MA.
  • Partridge A; Dana-Farber Cancer Institute, Boston, MA.
  • Winer EP; Harvard Medical School, Boston, MA.
  • Krop I; Dana-Farber Cancer Institute, Boston, MA.
J Clin Oncol ; 39(21): 2375-2385, 2021 07 20.
Article in En | MEDLINE | ID: mdl-34077270
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: